The Ulysses Strategy
“The Ulysses Strategy” – The New Yorker
“The Ulysses Strategy” – The New Yorker
A former student of mine who now works at the Advisory Board recently emailed me some figures her company put together, offering a snapshot of how many people are being hired in oncology practices to help patients with their financial concerns: I am very eager to see what these figures look like over the next…
A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth or eradicated the men’s cancers with surgery or radiation. What does this study mean for patients? Based on research we have conducted on prostate cancer decision-making,…
Among people receiving hospice care, the last few days of life can be intense, with progression of pain or breathing problems or other symptoms of their terminal illnesses. For those who die on Sundays, that means they are less likely to see doctors or nurses in the last days of life:
“Promoting Population Health through Financial Stewardship” – The New England Journal of Medicine
There’s plenty of price gouging in American healthcare. The pharmaceutical industry has gotten plenty of (well deserved) bad press for its pricing practices. At the extreme are people like “Pharma Bro” (and convicted felon) Martin Shkreli, who hiked the price of an important medication to treat infections in AIDS patients by over 5000%. But high and…
Shutterstock Recently I posted a piece, describing research out of Johns Hopkins, showing that when patients come to ERs – either with no insurance or insurance that is out-of-network – they often face charges that are four, six, or even ten-fold greater than what Medicare would pay for the same services. After the post, I was inundated…